Signaling pathways involved in thyroid hyperfunction and growth in Graves' disease.
The elucidation of the multiple signaling cascades coupled to the TSH receptor has offered new approaches in the understanding of the pathogenesis of Graves' disease. Here we review findings showing that immunoglobulins from Graves' patients are heterogeneous, bind to different epitopes and, similarly to TSH, activate different signaling pathways, including adenylyl cyclase, phospholipase C and phospholipase A2. Evidence that the multiplicity of signals correlates with the different manifestations of the disease is also summarized. We believe that the dissection of the molecular mechanisms involved in the pathogenesis of Graves' disease offers the basis for developing novel therapeutical approaches to this disease.
Di Cerbo
A
A
Division and Research Unit of Endocrinology, Istituto di Ricovero e Cura a Carattere Scientifico Casa Sollievo della Sofferenza General Hospital, San Giovanni Rotondo, Foggia, Italy.
Corda
D
D
D000818:Animals; D006111:Graves Disease / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D011989:Receptors, Thyrotropin / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology*; D013961:Thyroid Gland / Q000254:growth & development* / Q000503:physiopathology*
D007074:Immunoglobulin G; D011989:Receptors, Thyrotropin